Preview

Rational Pharmacotherapy in Cardiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 16, No 2 (2020) Treatment of Patients with COVID-19 and Concomitant Cardiovascular Diseases: Do not Forget About the Principles of Evidence-based Medicine Abstract  similar documents
S. Yu. Martsevich
"... and angiotensin II receptor antagonists (ARA) in patients with COVID-19 is analyzed in the article ..."
 
Vol 6, No 1 (2010) ANGIOTENSIN II RECEPTOR ANTAGONISTS AND ACE INHIBITORS: OPTIMIZATION OF CHOICE FOR TREATMENT OF CARDIOVASCULAR DISEASES Abstract  similar documents
E. M. Khurs, A. V. Poddubnaya
"... receptor antagonist (ARA), valsartan at the cardiovascular continuum (CVC) stages. Material and methods ..."
 
Vol 6, No 6 (2010) NEW POSSIBILITIES OF STATIN THERAPY IN ARTERIAL HYPERTENSION Abstract  similar documents
E. M. Khurs, A. V. Poddubnaya, M. G. Evsina, E. M. Futerman, O. G. Smolenskaya
"... + diet), group A2 (ACE inhibitor + fluvastatin), group B1 (angiotensin II receptor antagonist (ARA II ..."
 
Vol 5, No 3 (2009) FREE-RADICAL OXIDATION ACTIVITY IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION WITHOUT Q WAVE TREATED WITH EPROSARTAN OR ENALAPRIL ADDITIONALLY TO THE BASIC THERAPY Abstract  similar documents
O. G. Zaylobidinov, Yu. N. Ziyaev, N. K. Kamilova, A. S. Khalilov, B. F. Mukhamedova
 
Vol 4, No 1 (2008) EFFECT OF ANGIOTENSIN-II RECEPTOR ANTAGONIST LOSARTAN AND ITS COMBINATION WITH DIURETICS ON MYOCARDIAL MORPHO-FUNCTIONAL CONDITIONS IN HYPERTENSIVE PATIENTS WITH LEFT VENTRICULAR HYPERTROPHY Abstract  similar documents
S. N. Tolpygina, E. V. Oschepkova, L. M. Sergakova, A. N. Rogoza
"... Aim. To compare the effects of long-term therapy with angiotensin-II receptor antagonist losartan ..."
 
Vol 4, No 4 (2008) PLACE OF ANGIOTENSIN II RECEPTOR ANTAGONISTS IN ARTERIAL HYPERTENSION THERAPY Abstract  similar documents
S. A. Boytsov, I. P. Kolos
"... Angiotensin II receptor antagonists (ARA) established their position recently duet to new ..."
 
Vol 5, No 4 (2009) TO THE 110-TH ANNIVERSARY OF RENIN FINDING. FIGHT OF TITANS: ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND SARTANS Abstract  similar documents
L. N. Malay, A. N. Miroshnichenko, B. V. Sharykin, V. V. Konurovsky
"... Angiotensin converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARB) slow ..."
 
Vol 13, No 3 (2017) ANGIOTENSIN RECEPTOR BLOCKERS WITH PLEIOTROPIC PROPERTIES: A NEW STANDARD IN CARDIOVASCULAR RISK MANAGEMENT AND TREATMENT OF HYPERTENSION Abstract  similar documents
V. I. Podzolkov, M. V. Pisarev
"... important mechanisms for the realization of the cardiovascular continuum. The role that angiotensin receptor ..."
 
Vol 9, No 4 (2013) ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS: IS THERE A REASON TO CONSIDER AN EQUIVALENCE OF TWO DRUG CLASSES FROM THE EVIDENCE BASED MEDICINE STANDPOINT Abstract  similar documents
S. Yu. Martsevich
"... ) and angiotensin receptor blockers (ARB) on cardiovascular diseases outcomes are evaluated. Data of the recent meta ..."
 
Vol 10, No 6 (2014) IRBESARTAN IN THE CLINICAL PRACTICE Abstract  similar documents
V. I. Podzolkov, A. I. Tarzimanova
"... (myocardial infarction, stroke, chronic heart and renal failure). Angiotensin receptor blockers are the first ..."
 
Vol 8, No 2 (2012) TELMISARTAN IN THE TREATMENT OF ARTERIAL HYPERTENSION. CASE STUDY Abstract  similar documents
V. I. Podzolkov, A. I. Tarzimanova
"... Data on angiotensin II receptor blockers, one of the main drug classes used in cardiology ..."
 
Vol 13, No 4 (2017) PATIENT WITH CHRONIC HEART FAILURE. RATIONAL CHOICE OF THERAPY Abstract  similar documents
O. M. Drapkina, D. U. Akasheva
"... with reduced ejection fraction (<40%). Antagonists of mineralocorticoid receptors, along with angiotensin ..."
 
Vol 9, No 6 (2013) POSSIBILITY OF ANGIOTENSIN RECEPTOR BLOCKERS IN OPTIMIZING OF ANTIHYPERTENSIVE PHARMACOTHERAPY IN PATIENTS AFTER STROK Abstract  similar documents
Z M. Sizova
"... Current possibilities of AT1 receptor blockers (ARBs), such as candesartan, for optimization ..."
 
Vol 11, No 6 (2015) Cardiometabolic properties of telmisartan: new perspectives for use Abstract  similar documents
O. M. Drapkina, E. I. Fomicheva
 
Vol 10, No 2 (2014) ADVANTAGES OF COMBINATION THERAPY OF HYPERTENSION WITH CALCIUM CHANNEL BLOCKER AND ANGIOTENSIN-CONVERTING ENZYME INHIBITOR IN PATIENTS WITH IMPAIRED RENAL FUNCTION Abstract  similar documents
N. A. Dzhaiani
"... disease are presented. Special attention is paid to the fixed combination of calcium antagonist ..."
 
Vol 4, No 5 (2008) INHIBITION OF KIDNEY DISORDERS IN CARDIOVASCULAR DISEASES: THE ROLE OF ANGIOTENSIN II RECEPTOR BLOCKERS Abstract  similar documents
V. V. Fomin
"... and cardiovascular complications are discussed with focus on usage of angiotensin II receptor blockers. ..."
 
Vol 13, No 2 (2017) PATIENTS WITH COMBINATION OF CHRONIC HEART FAILURE, HYPERTENSION AND HISTORY OF MYOCARDIAL INFARCTION: CLINICAL AND ANAMNESTIC CHARACTERISTICS, ADMINISTRATION OF ACE INHIBITORS, ANGIOTENSIN RECEPTOR BLOCKERS, -BLOCKERS AND ADHERENCE TO THE DRUG THERAPY (DATA OF OUTPATIENT REGISTRY RECVASA) Abstract  similar documents
M. M. Loukianov, A. N. Kozminsky, S. Yu. Martsevich, S. S. Yakushin, A. N. Vorobyev, A. V. Zagrebelnyy, R. P. Myasnikov, K. G. Pereverzeva, E. A. Pravkina, E. Yu. Andreenko, E. N. Belova, A. D. Deev, V. G. Klyashtorny, E. V. Kudryashov, S. A. Boytsov
"... converting enzyme inhibitors (ACEI)/angiotensin receptor blockers (ARB) and β-blockers in the outpatient ..."
 
Vol 17, No 2 (2021) Management of Patients with Chronic Heart Failure and Diabetes Mellitus Abstract  similar documents
E. V. Reznik, T. L. Nguyen, G. N. Golukhov
"... of the prescribed drugs. Angiotensin receptor-neprilysin inhibitor are increasingly used in clinical practice ..."
 
Vol 15, No 3 (2019) Hypertension and Headache: the Effect of Antihypertensive Drugs Abstract  similar documents
V. A. Parfenov, T. M. Ostroumova, O. D. Ostroumova
"... ; it is known that some angiotensin converting enzyme inhibitors (ACEI) and angiotensin II receptor blockers ..."
 
Vol 4, No 2 (2008) FROM THE SHORT ACTING NIFEDIPINE TO AMLODIPINE AND FIXED COMBINATIONS. HIGHLIGHTS THE PROBLEM FROM THE CURRENT GUIDELINES POINT OF VIEW Abstract  similar documents
L. I. Katelnitskaya, L. A. Haisheva
"... Calcium antagonists (CA) therapy of patients with arterial hypertension is focused on the base ..."
 
Vol 3, No 2 (2007) CALCIUM ANTAGONISTS IN CLINICAL PRACTICE: FOCUS ON METABOLIC AND VASCULAR EFFECTS Abstract  similar documents
D. V. Nebieridze
"... The efficacy of calcium antagonists widely used in cardiological practice is proved both ..."
 
Vol 9, No 1 (2013) LERCANIDIPINE, CALCIUM CHANNEL BLOCKER OF THE THIRD GENERATION: NEW POSSIBILITIES IN THE TREATMENT OF ARTERIAL HYPERTENSION Abstract  similar documents
O. D. Ostroumova, M. L. Maksimov, I. I. Kopchenov
 
Vol 16, No 4 (2020) Real-Life International Normalized Ratio Profile in Patients with Non-Valvular Atrial Fibrillation Prescribed Vitamin K Antagonist Abstract  PDF (Eng)  similar documents
S. I. Farag, O. S. Arafa, A.A. E. Hassan, H. M. Mashhour, A. M. Bendary
"... Coagulation status with vitamin K antagonists (VKAs) needs to be monitored carefully to ensure ..."
 
Vol 2, No 3 (2006) APPLICATION OF CALCIUM ANTAGONISTS IN PREVENTION OF CARDIOVASCULAR COMPLICATIONS DURING CARDIAC SURGERY Abstract  similar documents
S. V. Nedogoda
"... Results of randomized clinical trials on the usage of calcium antagonists (CA) in order to prevent ..."
 
Vol 2, No 4 (2006) CALCIUM ANTAGONISTS IN THE TREATMENT OF ARTERIAL HYPERTENSION DURING PREGNANCY Abstract  similar documents
R. I. Striuk
"... should be used immediately. Dihydropyridine calcium antagonists (CA) is drugs of choice for HT treatment ..."
 
Vol 3, No 4 (2007) RAMIPRIL IN THERAPY OF PATIENTS AFTER MYOCARDIAL INFARCTION Abstract  similar documents
I. V. Szirov, E. V. Malichenko
"... Angiotensin converting enzyme inhibitors are the first line medicine for the treatment of the most ..."
 
Vol 4, No 3 (2008) ANGIOTENSIN II AND MYOCARDIAL INFARCTION Abstract  similar documents
O. P. Shevchenko, А. О. Shevchenko
"... The role of angiotensin II in pathogenesis of cardiovascular diseases is discussed. Angiotensin II ..."
 
Vol 6, No 1 (2010) COMBINED ANTIHYPERTENSIVE THERAPY: ACE INHIBITOR PLUS CALCIUM CHANNEL BLOCKER. NEW ADVANTAGES OF THE KNOWN COMBINATION Abstract  similar documents
S. A. Boitsov, R. M. Linchak
"... attention is paid to usage of ACE inhibitor and calcium antagonist combination. ..."
 
Vol 13, No 2 (2017) ALDOSTERONE ANTAGONISTS. MODERN VIEWS ON THE MECHANISM OF ACTION AND EFFECTS OF SPIRONOLACTONE Abstract  similar documents
V. I. Podzolkov, N. A. Dragomiretskaya
"... The importance of renin-angiotensin-aldosterone system in pathogenesis of different clinical ..."
 
Vol 7, No 3 (2011) DIHYDROPYRIDINE CALCIUM ANTAGONISTS. POSITION OF NIFEDIPINE IN MODERN CARDIOLOGY PRACTICE Abstract  similar documents
A. A. Garganeeva
 
Vol 6, No 3 (2010) EFFECTS OF CALCIUM ANTAGONISTS OF THE THIRD GENERATION IN PATIENTS WITH ARTERIAL HYPERTENSION AND CONCOMITANT CHRONIC OBSTRUCTIVE PULMONARY DISEASE Abstract  similar documents
D. A. Yakhontov, N. F. Balabanova
"... of the second group received any other antihypertensive therapy except dihydropyridine calcium antagonists ..."
 
Vol 6, No 5 (2010) NEW APPROACHES OF THE HYPERTENSION TREATMENT: FROM CHOOSING THE BEST DRUG TO CHOOSE THE OPTIMUM DRUGS COMBINATION Abstract  similar documents
O. D. Ostroumova, E. A. Smolyarchuk, I. V. Khvorostyanaya
 
Vol 11, No 2 (2015) ANTICOAGULANT THERAPY IN EVERYDAY CLINICAL PRACTICE: DATA OF THE RETROSPECTIVE CROSS-SECTIONAL STUDY Abstract  PDF (Eng)  similar documents
V. A. Sulimov, D. A. Napalkov, A. A. Sokolova, A. V. Jilenko, O. S. Anikina
"... %) was revealed in 79%. 8.45% of the vitamin K antagonist treated patients developed hemorrhagic complications. 16 ..."
 
Vol 10, No 4 (2014) TREATMENT OF HYPERTENSION IN PREGNANCY: GUIDELINES AND CLINICAL EXPERIENCE Abstract  similar documents
O. V. Gaisenok, O. A. Zamyatina, N. Yu. Denisova, A. S. Leonov
 
Vol 3, No 1 (2007) DIHYDROPYRIDINE CALCIUM ANTAGONISTS: DATA OF EVIDENCE BASED MEDICINE AND RECOM-MENDATIONS ON PRACTICAL USE Abstract  similar documents
S. Y. Martsevich
"... The classification of calcium antagonists is presented. There were considered the results of large ..."
 
Vol 4, No 5 (2008) ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: ADVANTAGES OF CALCIUM ANTAGONISTS Abstract  similar documents
T. V. Adasheva, I. V. Fedorova, V. S. Zadionchenko, M. V. Macievich, V. V. Lee, S. V. Pavlov
 
Vol 7, No 1 (2011) NEW ANTIPLATELET DRUGS (PART 1) Abstract  similar documents
A. B. Sumarokov
"... of thromboxane and thrombin receptors. Clinical pharmacology of these drugs is different. This requires a doctor ..."
 
Vol 7, No 1 (2011) SUPPRESSION OF RENIN-ANGIOTENSIN SYSTEM TO PREVENT COMPLICATIONS OF CARDIOVASCULAR DISEASES: CURRENT "ROLES" DISTRIBUTION FROM CLINICAL PHARMACOLOGIST’S POINT OF VIEW Abstract  similar documents
S. R. Gilyarevskiy, V. A. Orlov, M. V. Golshmid, G. Yu. Zakharova, I. I. Sinitsina
"... A role of angiotensin-converting enzyme (ACE) inhibitors in cardiovascular diseases treatment ..."
 
Vol 6, No 5 (2010) THE USE OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS AFTER MYOCARDIAL INFARCTION. WHAT DO EVIDENCE-BASED MEDICINE DATA SPEAK FOR? Abstract  similar documents
S. Yu. Martsevich
"... The main trails proven angiotensin converting enzyme (ACE) inhibitor effects on the life prognosis ..."
 
Vol 10, No 3 (2014) RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM AND REPLICATIVE CELLULAR SENESCENCE: THEIR INTERACTION DURING THE VASCULAR AGEING Abstract  similar documents
V. S. Pykhtina, I. D. Strazhesko, M. V. Agaltsov, O. N. Tkacheva
"... is paid to the activation of the renin-angiotensin-aldosterone system as a source of chronic inflammation ..."
 
Vol 3, No 3 (2007) ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN ACUTE MYOCARDIAL INFARCTION: WHEN TO START THERAPY AND WHICH DRUG TO USE? Abstract  similar documents
S. Y. Martsevich, S. N. Tolpygina
"... Data of studies devoted to application of angiotensin converting enzyme (ACE) inhibitors in acute ..."
 
Vol 3, No 5 (2007) EFFECT OF SPIRAPRIL ON THE LENGTH OF INTERICTAL INTERVAL IN PAROXYSMAL ATRIAL FIBRILLATION Abstract  similar documents
L. N. Chikhireva, V. I. Malahov, E. S. Bykova, S. F. Sokolov
"... Aim. To evaluate effects of angiotensin converting enzyme inhibitor spirapril on efficacy ..."
 
Vol 9, No 2 (2013) FIXED COMBINATION OF THE CALCIUM CHANNEL BLOCKER LERCANIDIPINE AND ANGIOTENSIN CONVERTING ENZYME INHIBITOR ENALAPRIL: POSSIBILITY OF USAGE Abstract  similar documents
O. D. Ostroumova, I. I. Kopchenov
"... for different clinical situations are presented. Advantages and indications for combination of an angiotensin ..."
 
Vol 8, No 1 (2012) PHARMACOECONOMIC EVALUATION OF DABIGATRAN VS WARFARIN IN CARDIOVASCULAR EVENTS PREVENTION IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION Abstract  similar documents
Yu. B. Belousov, V. Yu. Mareev, I. S. Yavelov, D. Yu. Belousov
 
Vol 14, No 4 (2018) Risk Controlling of Gastrointestinal Bleeding in Comorbid Patients with Cardiovascular Diseases Abstract  similar documents
O. Yu. Chizhova, L. N. Belousova, I. G. Bakulin
"... with atrial fibrillation (AF) are of leading importance. Recently, non-vitamin K antagonist oral ..."
 
Vol 2, No 1 (2006) ANTIHYPERTENSIVE TREATMENT IN ELDERLY PATIENTS WITH DIHYDROPYRIDINE CALCIUM ANTAGONISTS Abstract  similar documents
Y. A. Karpov, V. V. Buza
"... . Advantages of dihydropyridine calcium antagonists (DPCA) for AH treatment in elderly patients are proved ..."
 
Vol 4, No 2 (2008) DIHYDROPYRIDINE CALCIUM ANTAGONISTS: THE ROLE IN CURRENT THERAPY OF CARDIO-VASCULAR DISEASES Abstract  similar documents
E. V. Shilova, S. Y. Martsevich
"... Classification of calcium antagonists (CA) is presented. Results of the large clinical trials ..."
 
Vol 15, No 1 (2019) Atherosclerosis and Osteoporosis. Common Targets for the Effects of Cardiovascular and Anti-osteoporotic Drugs (Part I). The Effect of Cardiovascular Drugs on Bone Strength Abstract  similar documents
I. A. Skripnikova, N. A. Alikhanova, M. A. Kolchinа, M. A. Myagkova, O. V. Kosmatova
"... of cardiovascular drugs, such as statins, beta-blockers, ACE inhibitors, diuretics, calcium antagonists and nitrates ..."
 
Vol 8, No 2 (2012) IMIDAZOLINE RECEPTOR AGONISTS: DO WE KNOW EVERYTHING ABOUT THEIR CAPABILITIES? Abstract  similar documents
D. V. Nebieridze, T. V. Kamyshova
"... The role of selective I1 imidazoline receptor agonists and moxonidine in particular , in modern ..."
 
Vol 8, No 6 (2012) SARTANS AND ANGIOTENSIN CONVERTING ENZYME INHIBITORS: A DUEL BETWEEN TWO LEADERS OF PHARMACOTHERAPY OF CARDIOVASCULAR DISEASES Abstract  similar documents
K. A. Gyamdzhyan, M. L. Maksimov
"... -angiotensin-aldosterone system are discussed. Efficacy and safety of two major cardiovascular drug classes ..."
 
Vol 7, No 5 (2011) NEW ANTIPLATELET DRUGS. PART 2 Abstract  similar documents
A. B. Sumarokov
"... are on their way to clinical application — prasugrel, ticagrelor , elinogrel, thromboxane receptor inhibitors ..."
 
Vol 8, No 5 (2012) TITERS OF ANTIBODIES TO Β1-ADRENOCEPTOR AND M2 CHOLINERGIC RECEPTORS IN PATIENTS WITH VENTRICULAR ARRHYTHMIAS WITHOUT AN ORGANIC CARDIOVASCULAR DISEASE AND THEIR POSSIBLE CLINICAL SIGNIFICANCE Abstract  similar documents
M. M. Rogova, N. A. Mironova, E. S. Rodionova, T. A. Malkina, K. A. Zykov, Zh. D. Bespalova, R. Sh. Bibilashvili, E. E. Efremov, S. P. Golitsyn
"... -cholinergic receptors, and to evaluate their possible contribution to the development and maintenance ..."
 
Vol 6, No 3 (2010) THE GENDER FEATURES OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN HYPERTENSIVE PATIENTS Abstract  similar documents
V. I. Podzolkov, A. E. Bragina, Ju. N. Rodionova, E. K. Panferova
"... Aim. To study the correlation of the renin-angiotensin-aldosterone system (RAAS) activity ..."
 
Vol 3, No 1 (2007) THE CAPABILITIES OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN CLINICAL PRACTICE: FOCUS ON VASOPROTECTION Abstract  similar documents
D. B. Nebieridze, A. S. Safaryan
"... Data of large-scale research that shows comprehensive abilities of an angiotensin converting ..."
 
Vol 14, No 6 (2018) Angiotensin Converting Enzyme Inhibitors and the Risk of Lung Cancer – New Scientific Evidences or Another Example of “Pseudo-Evidence” Medicine? Abstract  PDF (Eng)  similar documents
S. Yu. Martsevich
"... The quality of the database analysis that led to the conclusion that angiotensin converting enzyme ..."
 
Vol 17, No 1 (2021) A Clinical Case: the Risk Factors of Acute Kidney Injury in a Cardiological Patient Abstract  similar documents
E. A. Son, M. R. Kondratyuk, E. V. Fominykh, V. V. Fomin
 
Vol 15, No 4 (2019) The Therapy with Oral Anticoagulants in Patients with Atrial Fibrillation in Outpatient and Hospital Settings (Data from RECVASA Registries) Abstract  similar documents
M. M. Loukianov, S. Yu. Martsevich, O. M. Drapkina, S. S. Yakushin, A. N. Vorobyev, K. G. Pereverzeva, A. V. Zagrebelnyy, V. Val. Yakusevich, V. Vl. Yakusevich, E. M. Pozdnyakova, T. A. Gomova, E. E. Fedotova, M. N Valiakhmetov, V. P. Mikhin, Yu. V. Maslennikova, E. Y. Andreenko, V. G. Klyashtorny, E. V. Kudryashov, E. Yu. Okshina, M. A. Panagopulu, S. A. Boytsov
"... -vitamin K antagonist oral anticoagulants (NOAC) – 518 (16%). Patients with permanent and persistant types ..."
 
Vol 7, No 4 (2011) SARTANS OF THE SECOND GENERATION: THERAPEUTIC POTENTIAL EXTENSION Abstract  similar documents
S. V. Nedogoda
"... Peculiarities of the treatment with angiotensin II receptor blocker telmisartan are analyzed ..."
 
Vol 6, No 5 (2010) THE POLYMORPHISM OF Α2B-ADRENERGIC RECEPTOR GENE — A NEW GENETIC MARKER OF THE HEREDITARY SICK SINUS SYNDROME Abstract  similar documents
S. Iu. Nikulina, V. A. Shulman, A. A. Chernova, D. A. Nikulin, M. I. Voevoda, V. N. Maksimov
"... receptor (ADRA2B) polymorphism. Material and methods. 29 families with hereditary primary SSS from ..."
 
Vol 14, No 4 (2018) Role of Gut Microbiota in the Pathogenesis of Cardiovascular Diseases and Metabolic Syndrome Abstract  similar documents
O. M. Drapkina, O. E. Shirobokikh
"... modulate host lipid metabolism as well as carbohydrate metabolism through several receptors such as G ..."
 
Vol 8, No 3 (2012) EFFECT OF THE COMBINED ANTIHYPERTENSIVE THERAPY WITH TARGET BLOOD PRESSURE ACHIEVEMENT ON INTRARENAL BLOOD FLOW IN PATIENTS WITH TYPE 2 DIABETES Abstract  similar documents
O. A. Koshel'skaya, O. A. Zhuravleva
"... antihypertensive therapy with or without renin-angiotensin-aldosterone system (RAAS) inhibitors. Material ..."
 
Vol 13, No 1 (2017) VARIABILITY IN LEVELS OF LOW-DENSITY LIPOPROTEINS CHOLESTEROL IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA DEPENDING ON AGE AND SEX AND ITS IMPORTANCE IN THE DIAGNOSIS OF THIS DISEASE Abstract  similar documents
V. А. Korneva, T. Yu. Kuznetsova, G. P. Tihova
"... was performed in 102 patients (46.6%); pathogenic mutation in the LDL receptor was identified in 21 patients ..."
 
Vol 14, No 1 (2018) NFLUENCE OF CYP4F2*3 ON RESPONSE TO CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROME Abstract  similar documents
K. B. Mirzaev, O. D. Konova, E. A. Grishina, K. A. Ryzhikova, Zh. A. Sozaeva, D. A. Andreev, M. Y. Gilyarov, D. A. Sychev
 
Vol 9, No 1 (2013) POSSIBILITIES OF CLINICAL LABORATORY EVALUATION OF ANTIPLATELET THERAPY EFFECTIVENESS IN PATIENTS WITH ISCHEMIC HEART DISEASE Abstract  similar documents
O. V. Sirotkina, A. B. Laskovets, A. S. Lipunova, L. B. Gaykovaya, S. A. Boldueva, T. V. Vavilova
"... of glycoprotein (GP) IIb/IIIa receptor level and the expression of P-selectin before and after ADP induction ..."
 
Vol 15, No 6 (2019) Glycoprotein IIb/IIIa Receptor Inhibitors in Patients with ST-Segment Elevation Myocardial Infarction and Primary Percutaneous Coronary Intervention Abstract  similar documents
A. S. Tereshchenko, Е. V. Merkulov, A. M. Samko
"... or unrecoverable blood flow is the use of glycoprotein IIb/IIIa receptor inhibitors which is, in contrast ..."
 
Vol 2, No 2 (2006) METABOLIC SYSTEM OF CHOLESTEROL ELIMINATION FROM TISSUES. POSSIBILITY OF ACTIVATION ITS KEY PARTS Abstract  similar documents
N. V. Perova, I. N. Ozerova, V. A. Metelskaya
 
Vol 2, No 3 (2006) ANTITHROMBOTIC THERAPY OF ISCHEMIC HEART DISEASE: FROM FAST ACTING ANTIAGGREGANTS TO STATINES AND NITRATE OXIDE. IS IT REAL? Abstract  similar documents
I. A. Latfullin, A. A. Podolskaya
"... : selective thromboxane inhibitors, antagonists of thromboxane receptors, blockers of platelet receptors ..."
 
Vol 15, No 3 (2019) Atherosclerosis and Osteoporosis. Common Targets for the Effects of Cardiovascular and Anti-Osteoporotic Drugs (Part II). The Effect of Antiosteoporotic Drugs on the Vascular Wall State Abstract  similar documents
I. A. Skripnikova, O. V. Kosmatova, M. A. Kolchinа, M. A. Myagkova, N. A. Alikhanova
"... antiresorptive drugs (bisphosphonates, monoclonal antibodies to RANKL, selective estrogen receptor modulators ..."
 
Vol 17, No 5 (2021) Genetic Polymorphism of beta1-adrenergic Receptors and the Effect on the Clinical Efficacy of beta-adrenoblockers Abstract  similar documents
V. N. Larina, M. V. Leonova
"... is largely dependent on the genetic polymorphism of beta1-adrenergic receptors (ADRB1). The aim of the review ..."
 
Vol 11, No 4 (2015) INFLUENCE OF THE CYP3A4 ISOENZYME METABOLIC ACTIVITY AND CYP2C19 GENE POLYMORPHISMS ON CLOPIDOGREL ANTIPLATELET EFFECT IN PATIENTS WITH ACUTE CORONARY SYNDROME UNDERGOING PERCUTANEOUS CORONARY INTERVENTION Abstract  PDF (Eng)  similar documents
K. B. Mirzaev, R. E. Kazakov, V. V. Smirnov, D. A. Andreev, D. A. Sychev
 
Vol 14, No 6 (2018) P2Y12 Receptor Inhibitors in the Treatment of Patients with Acute Coronary Syndrome and Percutaneous Coronary Intervention: Possibilities of Prasugrel Abstract  PDF (Eng)  similar documents
N. M. Vorobyeva
"... The possibilities of P2Y12 receptor inhibitors application in the treatment of patients with acute ..."
 
Vol 12, No 3 (2016) GENETIC PREDICTORS OF ATRIAL FIBRILLATION Abstract  PDF (Eng)  similar documents
A. V. Kuskaeva, S. Yu. Nikulina, A. A. Chernova, N. V. Aksyutina
"... and angiotensin II receptor antagonists in the prevention of AF is revealed. RAAS blockers are able not only ..."
 
1 - 72 of 72 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)